MedPath

Apelin

Generic Name
Apelin

A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin

Phase 2
Active, not recruiting
Conditions
Cardiovascular Diseases
Type 2 Diabetes Mellitus
Interventions
Drug: Normal saline
Diagnostic Test: Verapamil
Diagnostic Test: LN Monomethyl arginine
First Posted Date
2018-02-28
Last Posted Date
2024-02-07
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
170
Registration Number
NCT03449251
Locations
🇬🇧

Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom

Effect of Apelin on Insulin Sensitivity in Type 2 Diabetic Volunteers

Phase 1
Completed
Conditions
Diabetes
Interventions
Drug: placebo
First Posted Date
2016-03-31
Last Posted Date
2017-08-22
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
9
Registration Number
NCT02724566
Locations
🇫🇷

University Hospitals of Toulouse (Rangueil), Toulouse, Midi-Pyrénées, France

Effect of Apelin on Insulin Sensitivity: Proof of Concept in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2014-01-10
Last Posted Date
2019-07-12
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
16
Registration Number
NCT02033473
Locations
🇫🇷

University Hospital of Toulouse, Toulouse, France

Effects of Apelin on the Lung Circulation in Pulmonary Hypertension

Not Applicable
Conditions
Pulmonary Arterial Hypertension
Heart Failure
Interventions
Drug: Saline (Placebo)
First Posted Date
2011-10-21
Last Posted Date
2013-07-15
Lead Sponsor
Golden Jubilee National Hospital
Target Recruit Count
63
Registration Number
NCT01457170
Locations
🇬🇧

Royal Infirmary Edinburgh, Edinburgh, United Kingdom

🇬🇧

Hammersmith Hospital, London, United Kingdom

🇬🇧

Golden Jubilee National Hospital, Glasgow, United Kingdom

Investigating the Inotropic Potential of Apelin

Not Applicable
Completed
Conditions
Heart Failure
Interventions
Drug: Placebo
First Posted Date
2010-08-10
Last Posted Date
2024-05-09
Lead Sponsor
University of Edinburgh
Target Recruit Count
24
Registration Number
NCT01179061
Locations
🇬🇧

Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Little France Cresc, Edinburgh, United Kingdom

🇬🇧

Gareth Barnes, Edinburgh, United Kingdom

🇬🇧

University of Edinburgh, Edinburgh, United Kingdom

Investigating Systemic and Local Vascular Responses to Apelin in the Context of Renin-angiotensin Upregulation

Not Applicable
Completed
Conditions
Heart Disease
Heart Failure
Vasodilatation
Interventions
First Posted Date
2009-05-14
Last Posted Date
2010-08-10
Lead Sponsor
University of Edinburgh
Target Recruit Count
12
Registration Number
NCT00901719
Locations
🇬🇧

Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Little France Cresc, Edinburgh, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath